Indivior Pharmaceuticals Inc
INDV
주식 순위
#3881
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
주가
$34.01
마지막 동기화: 2026-10-19
시가총액
$4.24B
변동 (1일)
4.81%
변동 (1년)
40.02%
국가
US
거래 Indivior Pharmaceuticals Inc (INDV)
카테고리
Healthcare
Indivior Pharmaceuticals Inc (INDV)의 P/B 비율
October 2026 기준 P/B 비율 TTM: -20.59
Indivior Pharmaceuticals Inc의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 -20.59입니다. 2023년 말 기준 P/B 비율은 31.28였습니다.
Indivior Pharmaceuticals Inc의 P/B 비율 기록 (2016 ~ 2026)
매년 말 P/B 비율
| 연도 | P/B 비율 | 변화 |
|---|---|---|
| 2026 (TTM) | -20.59 | 337.08% |
| 2024 | -4.71 | -115.07% |
| 2023 | 31.28 | -46.95% |
| 2022 | 58.97 | 375.46% |
| 2021 | 12.40 | -5.60% |
| 2020 | 13.14 | 623.09% |
| 2019 | 1.82 | -87.78% |
| 2018 | 14.87 | -176.13% |
| 2017 | -19.54 | 125.54% |
| 2016 | -8.66 | 0.00% |
유사 기업 또는 경쟁사의 P/B 비율
| 회사 | P/B 비율 | P/B 비율 차이 | 국가 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -124.49% |
IN
|
